Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Seamlessly bridge your LNP discovery journey from RUO to bulk GLP-tox and GMP excipient-grade material.
Explore CGMP Lipid ServicesH1L1A1B3 is an ionizable cationic lipid that has been used in combination with other lipids in the formation of lipid nanoparticles (LNPs) for the delivery of circular RNA (circRNA) in vitro and in vivo.1 LNPs containing H1L1A1B3 and encapsulating circRNA encoding IL-12 induce IL-12 production four times more effectively than LNPs containing ALC-0315 (Item No. 34337) and encapsulating the same circRNA in LLC1 murine Lewis lung carcinoma cells. Administration of LNPs containing H1L1A1B3 and encapsulating circRNA encoding IL-12 reduces tumor growth in an LLC1 murine Lewis lung carcinoma model in combination with an antibody against programmed cell death ligand 1 (PD-L1).
WARNING This product is not for human or veterinary use.
1. Tumor-